Century Therapeutics (IPSC) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Century Therapeutics (IPSC) over the last 3 years, with Q3 2025 value amounting to $0.05.
- Century Therapeutics' Debt to Equity changed N/A to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.05, marking a year-over-year change of. This contributed to the annual value of $0.03 for FY2022, which is N/A changed from last year.
- Latest data reveals that Century Therapeutics reported Debt to Equity of $0.05 as of Q3 2025.
- In the past 5 years, Century Therapeutics' Debt to Equity registered a high of $0.05 during Q3 2025, and its lowest value of $0.03 during Q1 2022.
- In the last 3 years, Century Therapeutics' Debt to Equity had a median value of $0.03 in 2022 and averaged $0.03.
- Examining YoY changes over the last 5 years, Century Therapeutics' Debt to Equity showed a top increase of 4338.69% in 2023 and a maximum decrease of 4338.69% in 2023.
- Century Therapeutics' Debt to Equity (Quarter) stood at $0.03 in 2022, then grew by 9.82% to $0.04 in 2023, then grew by 27.27% to $0.05 in 2025.
- Its Debt to Equity was $0.05 in Q3 2025, compared to $0.04 in Q1 2023 and $0.03 in Q4 2022.